A Randomized Vehicle-Controlled Trial to Assess the Efficacy, Safety, and Tolerability of Ozenoxacin 1% Cream in 412 Patients 2 Months and Older with Impetigo. J of Skin [Internet]. 2017 Oct. 27 [cited 2025 May 14];1(3.1):s103. Available from: https://skin.dermsquared.com/skin/article/view/178